Retatrutide (LY3437943; Eli Lilly) is a single peptide conjugated to a fatty diacid moiety and has agonism toward the GIP, GLP-1, and GCG receptors. As compared with the endogenous receptor ...

Ongoing research aims to delineate its full spectrum of activity, optimal strategies, and the breadth of its implications.

Given the scope of the risk, attention has turned to metabolic hormones that regulate appetite, satiety, and glucose metabolism, particularly glucagon-like peptide-1 (GLP-1). Its appetite ...

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...

B7-33, a synthetic analog of the relaxin-2 hormone, has emerged as a molecule of significant interest in the scientific community. This peptide, designed to selectively activate the relaxin family ...

Long-acting GLP-1 RAs approved for use in the United States include: Glucagon-like peptide-1 (GLP-1) is a hormone that plays important roles in regulating appetite and blood sugar levels.

Experimentation has shown that oxytocin, a peptide hormone primarily responsible ... This finding, along with the identification of oxytocin receptors in CNS neurons, has spurred interest in ...

The understanding so far has been that GLP-1 analogues work by mimicking the action of a similarly shaped molecule called glucagon-like peptide, which is naturally released by the intestines soon ...

Your doctor will check to see if your tumor has hormone receptors. If it does, they may call it "hormone-receptor positive," “ER-positive,” or “PR-positive.” For advanced cases ...

"I feel great," the Real Housewives of New Jersey star tells PEOPLE exclusively, of the peptide and hormone therapy she's been undergoing for a year Dave Quinn is a Senior Editor for PEOPLE.

About two-thirds of women with breast cancer have tumors that contain hormone receptors. This means a tumor has receptors for the hormone estrogen (called ER-positive) or the hormone progesterone ...